Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Prollenium US, Inc. v. Allergan Industrie, SAS
Case Number:
Case Type:
IPR
Status:
Terminated
Petitioner:
Prollenium US, Inc.
Patent Owner:
Allergan Industrie, SAS
Patent Number:
Tech Center:
1600
-
February 22, 2021
Allergan Patents Spared From PTAB Review In Settlement
The Patent Trial and Appeal Board said it won't review six Allergan patents covering the company's injectable skin filler Juvederm, despite expressing skepticism toward them, after Allergan announced it has inked a licensing agreement with the low-cost rival challenging the patents.
-
January 12, 2021
PTAB Judge Skeptical Allergan's Juvederm Patents Are Valid
Attorneys for Allergan had a tough time Tuesday persuading the Patent Trial and Appeal Board that six patents covering the company's injectable skin filler Juvederm are not obvious because they solved long-standing degradation problems with existing fillers, with one judge calling the argument "speculative."